Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Financial Performance & Income Statement Overview
Explore the financials of Fisher & Paykel Healthcare Corporation Limited (FSPKF), including yearly and quarterly data on income, cash flow, and balance sheets.
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Income Statement & Financial Overview
Review Fisher & Paykel Healthcare Corporation Limited FSPKF income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $951.20M | $939.10M | $815.80M | $894.10M |
| Cost of Revenue | $362.50M | $380.80M | $317.60M | $365.30M |
| Gross Profit | $588.70M | $558.30M | $498.20M | $528.80M |
| Gross Profit Ratio | $0.62 | $0.59 | $0.61 | $0.59 |
| R&D Expenses | $110.10M | $101.30M | $96.90M | $90.10M |
| SG&A Expenses | $260.50M | $256.20M | $236.60M | $229.60M |
| Operating Expenses | $370.60M | $357.50M | $333.50M | $319.70M |
| Total Costs & Expenses | $733.10M | $738.30M | $651.10M | $685.00M |
| Interest Income | $0.00 | $3.80M | $1.40M | $1.10M |
| Interest Expense | $0.00 | $19.00M | $8.70M | $5.50M |
| Depreciation & Amortization | $57.60M | $45.60M | $54.40M | $48.50M |
| EBITDA | $275.70M | $246.40M | $203.70M | $267.70M |
| EBITDA Ratio | $0.29 | $0.26 | $0.25 | $0.29 |
| Operating Income | $218.10M | $200.80M | $164.70M | $209.10M |
| Operating Income Ratio | $0.23 | $0.21 | $0.20 | $0.23 |
| Other Income/Expenses (Net) | -$11.70M | -$105.70M | -$24.10M | $4.60M |
| Income Before Tax | $206.40M | $95.10M | $140.60M | $213.70M |
| Income Before Tax Ratio | $0.22 | $0.10 | $0.17 | $0.24 |
| Income Tax Expense | $53.20M | $69.80M | $33.30M | $59.30M |
| Net Income | $153.20M | $25.30M | $107.30M | $154.40M |
| Net Income Ratio | $0.16 | $0.03 | $0.13 | $0.17 |
| EPS | $0.26 | $0.04 | $0.18 | $0.27 |
| Diluted EPS | $0.26 | $0.04 | $0.18 | $0.27 |
| Weighted Avg Shares Outstanding | $589.23M | $596.77M | $580.58M | $578.54M |
| Weighted Avg Shares Outstanding (Diluted) | $589.39M | $593.22M | $584.54M | $582.33M |
Over the last four quarters, Fisher & Paykel Healthcare Corporation Limited's revenue moved from $894.10M in Q4 2023 to $951.20M in Q2 2025. Operating income in Q2 2025 was $218.10M, with a strong operating margin of 23%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Fisher & Paykel Healthcare Corporation Limited remained robust at $275.70M, reflecting operational efficiency. Net income rose to $153.20M, with an EPS of $0.26. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan